The ₹400 Crore Revenue Miss Management Won't Address
Apollo Pipes missed Q1 FY27 revenue guidance by 26% (₹295 Cr vs. ₹400 Cr target), reported a net loss of ₹11.1 Cr, yet claims normalized 7% EBITDA without disclosing the exact inventory write-down. The day-1 stock pop (+2.1%) may underestimate the credibility gap.
₹295.4 Cr
+7.4% YoY but -26% vs ₹400 Cr guide
-₹11.1 Cr
YoY -236%; OPM 1.0%, NPM -3.7%
0%
Flat YoY; FY26 also flat
7%
Unverified in P&L; actual loss
The revenue miss and what it means
Apollo missed its Q1 FY27 revenue guidance of over ₹400 Crore by ₹104.6 Crore (26%), delivering ₹295.4 Crore instead. This is not a miss management has formally revised; instead, it has pivoted to a narrative about H2 recovery, without near-term milestones or quantified targets for Q2. The guidance miss, combined with zero volume growth despite an aggressive ₹5,000 Crore five-year target, signals execution risk and raises questions about management's credibility.
Where the loss came from
Apollo reported a net loss of ₹11.1 Crore in Q1. Management attributes the majority to inventory write-downs related to PVC price volatility (April crash of ₹32/kg), but refuses to quantify the exact amount, saying 'simple math you can do.' This lack of transparency obscures the actual cash impact and makes it impossible to independently verify the claimed normalized 7% EBITDA. The actual P&L shows a loss, not a margin.
When I say our business EBITDA margin was 7% in consol levels, EBITDA which came, majority was inventory losses.
Q1 revenue guidance over ₹400 Cr
ContradictedDelivered ₹295.4 Cr, a 26% miss. No formal revision disclosed.
Normalized EBITDA 7% consolidated despite reported loss
ContradictedNet loss -₹11.1 Cr; inventory write-down magnitude unquantified. Cannot verify normalization from P&L.
Flat volume YoY = market share gain as smaller players hurt by volatility
UnverifiedNo competitor data, industry volume contraction size, or absolute market share provided. Unsubstantiated.
High double-digit volume growth FY27 & 7-8% EBITDA next 12-15 months
OverstatedQ1 delivered 0% volume growth; margin at -3.7% NPM. Recovery contingent on post-monsoon demand + price stability (both unproven).
What changed on this call
Revenue guidance missed by ₹104.6 Cr (-26%); no formal lowering of FY27 target
Profitability turned negative (-₹11.1 Cr net loss) from prior profit; margin compression unaddressed
Volume growth zero (0% YoY); flat in FY26 and Q1 FY27—no organic growth in 4+ quarters
Window profile launched (D2C); targeting 7-8% of FY27 revenue (nascent, unproven at scale)
Kisan restructuring ongoing; subsidiary still loss-making; only ~1% cost synergies quantified
The bull-bear ledger
Bull: Long-term ₹5,000 Cr FY31 target is quantified; ambitious 35% revenue CAGR with four ₹800–1,000 Cr plants
Bull: CPVC grew YoY despite flattish overall volumes; Lubrizol co-branding partnership gaining traction
Bull: PVC resin MIP floor at ₹82/kg provides price stability; channel restocking catalyzed by 10–15 day hold
Bear: Revenue guidance missed by 26% (₹400 Cr → ₹295 Cr); no formal FY27 revision erodes credibility
Bear: Net loss -₹11.1 Cr; inventory write-downs majority but unquantified, normalized claims unverifiable
Bear: Volume flat (0% YoY) for 4+ quarters; zero organic growth contradicts aggressive narrative
Bear: Distributor caution persists despite price stability; restocking timeline contingent on longer-term proof
Bear: Varanasi plant at 30% FY27 utilization; any shortfall delays entire ₹5,000 Cr roadmap
Bear: Kisan subsidiary hemorrhaging; merger synergies only 1% quantified; integration timeline opaque
Bear: Government capex (Nal Se Jal) stalled; zero tenders/disbursements 4 months into FY27
Risks, ranked by how much they should concern a holder
Guidance miss without formal revision
High₹400 Cr Q1 target vs ₹295 Cr delivered (-26%). No explicit FY27 reset; management pivoting to H2 narrative erodes credibility and visibility. Holder exposure to execution risk with no waypoints.
Profitability collapse and opaque accounting
HighNet loss -₹11.1 Cr with inventory write-downs 'majority' but unquantified. Normalized 7% EBITDA unverified in actual P&L. Cash vs. accrual impact unclear; holder cannot independently assess margin trajectory.
Volume stagnation (0% growth) vs. aggressive targets
HighQ1 flat YoY, FY26 flat, Kisan flat. Contradicts ₹5,000 Cr five-year narrative. If organic volume doesn't inflect, M&A (Kisan) and new products (Window) alone cannot drive growth; ramp-up milestones become unachievable.
PVC price volatility and distributor caution
HighApril 30% crash, June 5% decline. MIP floor at ₹82/kg provides stability but global cycles persist. Distributors 'very, very cautious' even in stable periods; require 10–15 day proof before restocking. Channel demand recovery unproven; Q2 upside contingent on macro factors outside management control.
Varanasi plant ramp-up execution
High30% utilization target (₹90 Cr of ₹300 Cr) in FY27; shortfall delays revenue and margin improvement. Capacity ramp is linchpin of ₹5,000 Cr roadmap. Macro headwinds (monsoon, PVC volatility, government capex delay) may suppress utilization below target.
Kisan subsidiary losses and merger credibility
HighLoss-making 3+ quarters. Claimed 5–6% EBITDA at business level (optical); P&L shows losses. Only ~1% cost synergies quantified; integration timeline unclear. If Kisan continues bleeding, merger is a drag on consolidated margin and ROI.
Government capex pipeline stalled
MediumNal Se Jal tenders/disbursements zero 4 months into FY27. O-PVC/HDPE volumes near-zero; major drag on overall growth. Budget support seen but process long and uncontrollable; private demand unproven for Apollo's growth target.
Window profile nascent and unproven
MediumD2C product targeting 7–8% of FY27 revenue; scales to 10%, long-term 15%. Team build-out inflating costs near-term. Execution risk high; new market and model unproven at scale. If ramp misses, credibility hit compounds.
How the street is positioned
Price and trend: Apollo closed at ₹513 as of 2026-08-03, trading above its SMA20 (₹497.86), SMA50 (₹494.39), and SMA200 (₹387.76)—technically bullish. However, it sits -7.26% from its all-time high of ₹553.15 and +102.93% off its 52-week low of ₹252.8. The RSI of 53.1 is neutral. Volume trend is increasing.
Result reaction: The stock rose 2.1% on day 1 post-announcement (delivery 46.6%), a modest pop. This move is not commensurate with the severity of the fundamentals—a 26% revenue miss and net loss deserve deeper scrutiny. The market may be discounting the miss as a 'soft quarter' contingent on H2 recovery, or it may be underweighting the credibility gap. Either way, the modest pop signals limited conviction and significant downside risk if H2 fails to deliver volume growth and margin normalization.
Ownership and flows: FII ownership fell 1.36pp to 2.22% (Q4 FY26), while DII ownership fell 1.67pp to 10.76%. Promoter ownership rose 4.88pp to 51.72%—the largest single-quarter increase in recent history. This dual signal is telling: promoter buying into weakness can signal conviction, but when paired with FII and DII exits, it suggests internal confidence is not shared by institutional voters. Institutions are trimming exposure into the miss.
Bulk and block activity: In March 2026, CLASSIC ENTERPRISES sold 5,00,000 shares at ₹416 to AMICORP CAPITAL (MAURITIUS), while S GUPTA HOLDING (likely promoter-linked) bought 2,50,000 shares at ₹317. The March sale by CLASSIC at ₹416 (closer to current ₹513) suggests insiders were lightening near mid-range, not riding the current levels to the highs. The promoter buying at ₹317 is consistent with recent QoQ consolidation.
The reconciliation: Technically, the stock looks bullish—above moving averages, up 103% off its 52-week low. But the day-1 pop of only +2.1% (with moderate 46.6% delivery) after a 26% revenue miss and net loss suggests the market is hedging its bets. FII and DII exits combined with promoter consolidation point to a widening information or conviction gap. The modest price reaction and negative institutional flows may be early signals of a credibility reset if H2 does not deliver.
The debate
What to watch next
1 · PVC price stability window (Aug–Sep 2026)
If MIP floor at ₹82/kg holds for 10–15 consecutive days, distributor restocking should accelerate and Q2 volume recovery should begin. This is the first concrete test of the 'H2 recovery' narrative.
2 · Q2 volume growth (announced Sep–Oct 2026)
Management guided high double-digit volume growth in H2. Q2 must deliver proof: specific YoY volume growth % (not just 'double-digit'), segment-wise breakdown, and absolute ton production. Shortfall re-rates the entire five-year roadmap downward.
3 · Varanasi plant utilization (Q2 on-call)
FY27 target is 30% utilization (₹90 Cr of ₹300 Cr capacity). Q2 utilization % is a leading indicator of ramp trajectory. If trending toward 20% or below, execution risk is real and timeline extensions delay margin improvement.
4 · Monsoon exit demand surge (Oct–Nov 2026)
Post-monsoon (late Sep onwards), construction demand should rebound. If pent-up demand from Q1 soft quarter does not materialize, the 'temporary headwind' framing breaks. Watch for any guidance downgrades or revised timelines.
5 · Kisan margin and integration progress (H2 on-call)
Kisan is still loss-making despite a claimed 5–6% EBITDA at business level. If H2 does not show Kisan returning to profitability or synergies accelerating beyond 1%, merger credibility is damaged and consolidated margin improvement is at risk.
The bottom line
Apollo Pipes' Q1 FY27 results exposed a significant credibility gap: a 26% revenue miss, a net loss, zero volume growth, and evasive disclosure on inventory write-downs all contradict the aggressive ₹5,000 Crore five-year narrative. The day-1 stock pop of +2.1% suggests the market is hedging—giving management the benefit of the doubt on 'soft quarter' seasonality, but not committing new capital. FII and DII exits combined with promoter consolidation point to a divergence in conviction.
The company's recovery hinges entirely on post-monsoon volume uptake, price stability, and Varanasi ramp execution—all unproven and heavily dependent on macro factors outside management control. If Q2 does not show high double-digit volume growth and normalized margins trending back to 7–8%, the stock is at risk of a material re-rating downward. The honest read is that Apollo is a steady operator in a cyclical market, not a step-change growth story. Rating: Hold. The single number to track is Q2 volume growth YoY—high double-digit is non-negotiable for the bull thesis to survive.
Q1 guidance miss masks margin crunch; H2 recovery unproven
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Missed Q1 ₹400 Cr guidance (delivered ₹295 Cr, -26%). No formal FY27 revision; pivoting to H2 without near-term milestones.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Apollo missed Q1 FY27 revenue guidance by 26% (₹295 Cr vs ₹400 Cr) and reported a net loss of -₹11.1 Cr. Management's claim of normalized 7% EBITDA is unverified; the actual P&L and future recovery depend entirely on post-monsoon volume uptake and sustained price stability—both unproven in the call. Risk is high.
₹295.4 Cr
Revenue · +7.4% YoY₹-11.1 Cr
Reported PAT · −236.2% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Q1 revenue guidance over ₹400 Cr
MISSDelivered ₹295.4 Cr, a 26% miss. No formal revision disclosed.
Normalized EBITDA 7% consolidated despite reported loss
MISSNet loss -₹11.1 Cr; inventory write-down magnitude unquantified. Normalized claim unverified in P&L.
Flat volume YoY = market share gain as smaller players hurt by volatility
UnverifiedNo data on competitor impact, industry volume contraction size, or absolute market share. Claim unsubstantiated.
CPVC grew YoY despite flattish overall volumes
UnverifiedManagement asserts growth; no quantified numbers. Cannot verify.
Inventory losses were majority of EBITDA miss; margins normalizeable to 7-8%
OVERSTATEDExact inventory loss refused ('simple math you can do'). Actual P&L shows loss. Normalization optical.
Earnings quality
What changed since the last call
Revenue guidance missed
DowngradeQ1 FY27 target >₹400 Cr; delivered ₹295.4 Cr (-26%). No formal revision of FY27 target; just pivoting to H2 narrative.
Profitability turned negative
DowngradeQ1 net loss -₹11.1 Cr vs prior profit. Margin compression from inventory write-downs + aggressive pricing not pre-warned. QoQ PAT down 8,584%.
Volume growth zero
DowngradeFY26 flat YoY; Q1 FY27 also flat YoY. No organic volume growth in 4+ quarters despite aggressive 5-year ₹5,000 Cr guidance.
Window profile launched
NewNew D2C business targeting 7-8% of FY27 revenue (unproven at scale). Long-term potential 15%; near-term margin drag from team build-out.
Kisan restructuring ongoing
NeutralMerger scheme filed; plant closures, brand relaunch progressing. Still loss-making; only ~1% cost synergies quantified. Benefits timeline unclear.
The Q&A
Moderate pressure but not sustained. DAM Capital (Aasim) pressed hard on 7-8% margin confidence amid high competitive intensity and volume focus; management held firm but declined to quantify inventory loss amount ('simple math'). No analyst directly challenged the ₹400 Cr Q1 miss. Distributor caution (Roshan, Antique) and Kisan losses (Karan, AM Tech) prompted explanations but were not rebutted with hard data.
MIP & PVC pricing impact — Sneha, Nuvama
AnsweredMIP at ₹82/kg provides floor. Market 1-2% premium above floor. Prices stable in near term; cannot fall below MIP. Demand good due to low channel inventory.
Demand segment slowdown drivers — Sneha, Nuvama
AnsweredApril worst (30% PVC crash); both segments hit. May-June recovery pent-up. July decent. Monsoon to soften 15-20 days; construction will dominate H2.
One-off margin impact quantification — Sneha, Nuvama
PartialNormalized EBITDA 7% (8% Apollo, 6% Kisan). Varanasi + Window = 0.5% cost drag. Rest was inventory write-down. [Refuses to quantify write-down amount.]
Volume & margin guidance reaffirmation — Sneha, Nuvama
AnsweredHigh double-digit volume growth FY27 & coming years. 7-8% EBITDA next 12-15 months; gradual improvement after.
Window profile revenue targets — Ameya, Value Equity
Partial7-8% of FY27 revenue target. 10% at full capacity; 15% long-term. Flat volume vs contracting industry suggests market share gain.
Q2 YoY growth outlook — Sagar, Bajaj Alternate
AnsweredQ2 will be double-digit growth on YoY basis.
Five-year targets reconfirmation — Sagar, Bajaj Alternate
AnsweredFY31: four large plants (₹800-1,000 Cr each) + PVC pipes at 10%+ EBITDA. Allied products ₹1,000 Cr total. 25% ROC math maintained.
CAPEX funding approach — Sagar, Bajaj Alternate
AnsweredAlmost net cash. ₹600-700 Cr FY27-31 CAPEX; 70-80% from internal cash. No debt or equity needed.
New product margin expectations — Sagar, Bajaj Alternate
Answered10-15% EBITDA margin target. Focus on 25% ROC.
Government capex & Nal Se Jal pipeline — Neha, Nuvama
AnsweredBudget support seen but tender & disbursement slow. Nothing yet 4 months in FY27. Hoping for activity in next 3-4 months.
CPVC growth & Lubrizol partnership — Neha, Nuvama
AnsweredCPVC grew YoY despite flattish overall. Tie-up showing results. Co-branding activities underway; major growth contributor.
FY27-28 CAPEX quantum — Neha, Nuvama
Answered₹200 Cr total (₹100 Cr/year). Funded from operating cash; WC release expected Sep onwards.
Working capital release initiatives — Aasim, DAM Capital
AnsweredInventory 80 days; target rationalize to 30 day NWC (from 45). Debtors stable 30 days; target 25 by year-end. Creditor terms to improve with volume. 10-15 day WC release scope by FY28.
Confidence in 7-8% margins amid competition — Aasim, DAM Capital
PartialYes. Q1 showed it (normalized 7%). High push sales period. As normalization occurs, 50-100 bps room. Varanasi & Window stabilization add another 50-100 bps.
Inventory loss magnitude disclosure — Aasim, DAM Capital
DodgedNormalized 7% EBITDA; majority was inventory. [Declines to quantify; says 'simple math'.]
PVC resin supply & MIP effect — Aasim, DAM Capital
AnsweredPort congestion temporary. Global availability normal. MIP provides base; people importing again now. No supply disruption foreseen.
Segment demand evolution (agri, plumbing, infra) — Roshan, Antique
AnsweredConstruction (60% sales) ok in May-June. Agri slow due to monsoon; normal in Mar-Apr but April crashed with PVC prices. Construction now dominant.
Distributor restocking & July demand — Roshan, Antique
AnsweredToo early to restock; prices too volatile historically. Very cautious. If stability sustains 10-15 days, restocking will start and boost Q2.
Varanasi plant ramp trajectory — Karan, AM Tech
AnsweredTotal capacity ₹300 Cr. Target 30% utilization FY27. Then 50%, 60%, 70% in FY28, balance FY29.
Kisan losses vs merger confidence disconnect — Karan, AM Tech
PartialSilver lining: 5-6% EBITDA at business level (hidden by inventory losses in P&L). Volume flat 5.5k tons/qtr but can do 8-8.5k. Team rationalization, brand relaunch progressing. Macro improving.
Segment-wise volume growth — Karan, AM Tech
AnsweredFY26 & Q1 flat. CPVC strong, Window ramping, Bath flat, Water tank double-digit, Govt infra near-zero (major drag), Fittings single-digit.
ROC profile for ₹5,000 Cr revenue target — Karan, AM Tech
AnsweredGross block ₹1,500 Cr; WC ₹300-400 Cr; total capital ₹1,800-1,900 Cr. On ₹5,000 Cr @ 10-12% EBITDA (₹500-600 Cr), ROC = 25%. Math unchanged.
₹200 Cr CAPEX allocation & South India timing — Karan, AM Tech
AnsweredPending Varanasi, brownfield, new products. South India: FY27 land, FY28 Q2+ construction. Milestones: Varanasi & Maharashtra ramp first.
Kisan merger cost synergies — Shaurya, Equirus
PartialAlready achieved: single sourcing, finance/tech. Remaining: ~1% cost synergies post-merger (separate brands/teams). Timeline not specified.
Regional expansion strategy beyond South — Shaurya, Equirus
AnsweredPlants positioned: Secunderabad (North), Kisan (West: MH/GJ/MP), Varanasi (UP/Bihar/Odisha), planned South. 1-2 satellite plants post full-ramp.
Guidance
FY27 high double-digit volume growth
MediumUnquantified percentage. Q1 flat; recovery contingent on post-monsoon demand + price stability. Distributor caution persists as of late July.
Q2 double-digit growth YoY
MediumConditional on 10-15 day price stability window and monsoon exit. May not materialize if volatility or caution persists.
Window profile 7-8% of FY27 revenue
LowBrand-new D2C product. Unproven scale-up. Scales to 10% at capacity; long-term 15%. High execution risk.
FY31 ₹5,000 Cr revenue; 4 plants ₹800-1,000 Cr each; 10%+ EBITDA
MediumQuantified target; mechanism weak. Varanasi 30% FY27, Kisan still in recovery, South plant not yet started. Macro-dependent.
7-8% EBITDA next 12-15 months
LowQ1 actual net loss -₹11.1 Cr. Normalized 7% unverified. Contingent on volume uptake + cost absorption; high execution risk.
Gradual margin improvement post 12-15 months
MediumVaranasi & Window stabilization to add 50-100 bps. Timeline depends on volume ramp; unproven.
New product margins 10-15% EBITDA, 25% ROC target
LowAggressive target. Nascent businesses (Window, Water tank). No evidence of delivery yet.
FY27-28 ₹200 Cr CAPEX (₹100 Cr/year)
HighVaranasi completion, brownfield expansions, new products. Funded from internal cash flow; 70-80% coverage from operations.
FY31 ₹600-700 Cr cumulative CAPEX for ₹5,000 Cr revenue target
MediumSouth India plant FY27 land acquisition, FY28 Q2+ construction. Dependent on Varanasi/Maharashtra ramp-up milestones.
Risks the call surfaced
Guidance miss without revision
HighQ1 revenue missed ₹400 Cr guidance by 26% (₹295.4 Cr delivered). No formal lowering of FY27 target; just pivoting to H2 recovery narrative. Visibility gap erodes credibility.
Profitability collapse
HighNet loss -₹11.1 Cr in Q1. Inventory write-downs claimed as 'majority' but unquantified. Normalized 7% EBITDA unverified. Actual margin trajectory unknown.
Volume stagnation
HighQ1 volume flat YoY; FY26 also flat. No growth in 4+ quarters. Claim of market share gain from smaller player disruption is unsubstantiated; industry contraction size unknown.
PVC price volatility
HighApril 30% PVC crash; May stabilized. MIP floor at ₹82/kg but global cycles may persist. Channel partners remain very cautious; restocking delayed.
Distributor caution & demand uncertainty
HighDistributors 'very, very cautious' on restocking even with PVC stable (as of late July). Require sustained 10-15 day stability before major restock. Q2 upside unconfirmed.
Varanasi plant ramp-up execution risk
HighVaranasi targeting 30% utilization in FY27 (~₹90 Cr). Any shortfall delays ₹5,000 Cr revenue roadmap. Execution unproven; macro-dependent.
Kisan subsidiary losses & merger risk
HighKisan loss-making 3+ quarters; management claims 5-6% EBITDA at business level (optical) but P&L shows losses. Only ~1% cost synergies quantified; integration timeline unclear.
Government capex pipeline stalled
MediumNal Se Jal budget support seen but no tenders/disbursements yet 4 months into FY27. O-PVC/HDPE volumes near-zero; major drag on overall growth.
Window profile nascent & unproven
MediumWindow profile targeting 7-8% of FY27 revenue; scales to 10%, long-term 15%. D2C model new; team build-out inflating costs. Execution risk high.
South India plant timing uncertain
MediumSouth India plant in land ID phase; FY27 land acquisition, FY28 Q2+ construction start. Delays if Varanasi/Maharashtra ramp miss. Geographic footprint expansion uncertain.
Management
Score 6/10. Evasive on specifics; avoids quantifying inventory loss ('simple math'), margin bridge, and segment contribution. Pivots from Q1 miss to H2 narrative without concrete milestones. Claims of normalized 7% EBITDA unverified in actual P&L. Poor track record. Missed Q1 ₹400 Cr revenue guidance by 26% (₹295.4 Cr delivered). Volume flat FY26 & Q1; zero growth in 4+ quarters. Kisan subsidiary bleeding despite merger confidence.
1 · Aug-Sep 2026
PVC price stability window; if ₹82/kg holds 10-15 days, distributor restocking expected to accelerate
2 · Sep-Oct 2026
Monsoon exit; construction & agri demand rebound. Pent-up demand from Q1 soft quarter may drive H2 volume.
3 · Q2 FY27 onwards
Varanasi plant ramp-up; 30% utilization target. Shortfall signals execution risk and delays ₹5,000 Cr roadmap.
Risk is high.
Apollo Pipes swings to ₹11 Cr Q1 consolidated loss on margin collapse; revenue misses goal
revenue +7.43% · margins compressing
₹295.43 Cr
+7.43% YoY
₹-11.11 Cr
-3.73%
-6.7pp YoY
₹-2.52
Apollo Pipes swung to a consolidated net loss of ₹11.11 Cr in Q1 FY27 from a ₹8.16 Cr profit a year ago, even as consolidated revenue grew 7.4% YoY to ₹295.43 Cr — a rare topline-up, bottom-line-negative print. Sequentially revenue fell 14.9% from Q4's ₹347.02 Cr and the small ₹0.13 Cr prior-quarter loss deepened sharply. The damage is entirely at the margin: consolidated PBT was -₹12.64 Cr versus +₹9.13 Cr a year ago, with EBITDA collapsing to roughly ₹5 Cr (~1.8% of sales) from a 7.5% operating margin in the year-ago quarter. This is a margin-collapse story, not a demand story — cost of materials consumed stayed elevated at ₹230.5 Cr against ₹212.4 Cr on similar volumes, consistent with the aggressive market-share pricing management flagged on the Q4 call; the price-led volume push has compressed realisations faster than it has added revenue.
Q1 FY-2027 vs prior quarters
Against its own guidance the quarter is a clear miss: management had targeted Q1 FY27 consolidated revenue above ₹400 Cr and a five-year 35% revenue CAGR, but delivered ₹295 Cr — below even the ₹347 Cr it did last quarter — and the EBITDA-per-tonne improvement it promised went the wrong way. There are no exceptional items on either side, so the swing to loss is fully underlying; no adjustment applies. There is no formal street consensus on record for a company this size, and no brokerage preview with numbers turned up — MarketsMojo has an active 'Sell' on weak financials, but no consensus estimate exists to grade the print against.
The stock went into the print at ₹487.55, up 1.7% over the past month of trading.
Management has issued a very aggressive five-year guidance, targeting a 35% revenue CAGR to reach INR 5,000 crores by FY31, supported by a near-term Q1 FY27 revenue goal of over INR 400 crores. This growth will be driven by ramping up existing plants, establishing a new South India facility, and expanding allied produc
— This quarter: missed
Standalone tells a milder version of the same story — a ₹4.40 Cr loss versus a ₹8.11 Cr profit year ago on revenue of ₹244.3 Cr — so the extra ₹6.7 Cr of consolidated loss sits in the Kisan Moulding subsidiary (NCI loss of ₹2.55 Cr plus its share of the operating drag), a >2x divergence in loss magnitude that readers comparing the two numbers should note. This lands alongside the 26 June board approval of the amalgamation scheme folding Kisan Moulding and KML Tradelinks into Apollo Pipes (pending NCLT/exchange/shareholder approval); the loss-making subsidiary the merger absorbs is visibly dragging consolidated profitability today. The ₹0.70 final dividend (record date 17 July) and the 40th AGM on 4 August proceed against this weak quarter. The concall on 31 July will be the test of whether management still stands behind its ₹400 Cr-plus quarterly and ₹5,000 Cr-by-FY31 ambitions after a quarter that opened with a loss.
W1
Whether management reaffirms the >₹400 Cr quarterly revenue and ₹5,000 Cr-by-FY31 targets on the 31 July concall after opening FY27 with a loss
W2
EBITDA/tonne trajectory — guided ₹6,000-8,000 rising to ₹10,000-12,000; margins went negative-operating this quarter and must reverse
W3
Kisan Moulding turnaround under the pending amalgamation — subsidiary added ~₹6.7 Cr to the consolidated loss
Clean digital filing, headers unambiguous. No exceptional items either period. Consolidated 'Net Profit for period' -11.11 Cr is pre-NCI (matches DB convention); owner-attributable share is -8.57 Cr, NCI loss -2.55 Cr from Kisan Moulding subsidiary. Tax is a credit (deferred tax -1.52 Cr) on the pre-tax loss.